Womens Imaging: Page 161

Lymphadenectomy and radiotherapy not useful for early endometrial cancer
By Reuters Health
NEW YORK (Reuters Health), Dec 15 - Pelvic lymphadenectomy and adjuvant external-beam radiotherapy do not improve survival in women with early endometrial cancer, according to two reports appearing in the December 13 online issue of the Lancet.
December 14, 2008
Reuterslogo
Changes in breast density an early indicator of tamoxifen efficacy
By Reuters Health
NEW YORK (Reuters Health), Dec 12 - A reduction in breast density is a strong biomarker of response to tamoxifen chemoprevention, according to research reported Friday at the 2008 San Antonio Breast Cancer Symposium (SABCS).
December 11, 2008
Reuterslogo
Joint pain is increased in breast cancer patients
By Reuters Health
SAN ANTONIO, (Reuters Health), Dec 12 - Joint pain is more common and more severe in women with breast cancer than in age-matched controls without breast cancer, researchers reported at the 2008 San Antonio Breast Cancer Symposium (SABCS).
December 11, 2008
Reuterslogo
MRI helps predict breast cancer invasiveness at surgery
By Kate Madden Yee
CHICAGO - The use of breast MRI has increased by double-digits this year, a boost some industry watchers attribute to increased awareness of how the technology helps clinicians detect and treat breast cancer earlier in high-risk women.
November 30, 2008
Hormonal treatments do not impair cognitive function in women with breast cancer
By Reuters Health
NEW YORK (Reuters Health), Nov 30 - Concern that estrogen depletion in women with breast cancer may contribute to cognitive compromise does not appear to be warranted, at least over the short term, according to a report in the November 1 issue of Cancer.
November 29, 2008
Reuterslogo
Norwegian mammo study claims to find cancer 'spontaneous regression'
By Kate Madden Yee
A new study released today by Norwegian researchers offers an intriguing hypothesis: More frequent mammography screening intervals find some cancers that might otherwise "spontaneously regress" and would pose no threat were they not discovered.
November 23, 2008
Chemoradiotherapy feasible in breast cancer with brain metastases
By Reuters Health
NEW YORK (Reuters Health), Nov 21 - Breast cancer patients with brain metastases benefit from treatment with intravenous chemotherapy in combination with radiotherapy, according to a report in the November 1 issue of Cancer.
November 20, 2008
Reuterslogo
Bracco inks deal with Marillion
By AuntMinnieEurope.com staff writers
Italian contrast firm Bracco Imaging and oncology pharmaceutical developer Marillion Pharmaceuticals have signed a license agreement.
November 19, 2008
Dual-time-point FDG-PET/CT improves breast imaging accuracy
By Kate Madden Yee
Recent study results suggest that dual-time-point imaging with acquisition in the prone position improves PET/CT accuracy in patients with suspected breast cancer over single-time-point PET/CT. However, for lesions smaller than 10 mm, MRI shows higher sensitivity and should be preferred, according to the researchers.
November 17, 2008
2008 11 17 15 20 23 842 Figure4 B Thumb
Study reports link between breast toxicity and timing of rad therapy
By Cynthia E. Keen
The timing of treatment for breast cancer patients receiving external-beam radiation therapy (EBRT) following intraoperative radiation therapy (IORT) may be an important factor in preventing toxicity. Patients who receive EBRT sooner than five or six weeks after receiving IORT may have a higher risk of developing chronic late toxicity, according to a study by German researchers.
November 16, 2008
Single-session breast radiotherapy safe for pregnant women, study finds
By Cynthia E. Keen
Breast-conservation surgery becomes an option for pregnant women in their third trimester. For many of these women, radiation therapy can safely be postponed until after birth. But the option of breast-conserving surgery may become available to all pregnant women if electron-beam intraoperative radiation therapy (IORT) is used.
November 16, 2008
Hologic nets CE Mark for Celero
By AuntMinnieEurope.com staff writers
Women's imaging vendor Hologic has received CE Mark approval for its Celero vacuum-assisted spring-loaded core biopsy device.
November 5, 2008
Previous Page
Page 161 of 171
Next Page